# A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis

> **NCT00001422** · PHASE2 · COMPLETED · sponsor: **National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)** · enrollment: 20 (—)

## Conditions studied

- Arthritis, Psoriatic
- Psoriasis

## Interventions

- **DRUG:** fludarabine

## Key facts

- **NCT ID:** NCT00001422
- **Lead sponsor:** National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1995-06
- **Primary completion:** —
- **Final completion:** 2000-04
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001422, "A Controlled Trial of Intermittent Fludarabine for Psoriatic Arthritis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00001422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*